Organon & Co.OGNNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -0.38% | -6.72% | -0.81% | +1.26% | -5.34% |
| Gross Profit Growth | -2.08% | -12.12% | -6.92% | -7.15% | -15.29% |
| EBITDA Growth | +16.38% | -24.77% | +3.94% | +14.43% | -80.94% |
| Operating Income Growth | -5.13% | -21.50% | -15.54% | -8.21% | -20.61% |
| Net Income Growth | -80.04% | -56.72% | -25.64% | -55.43% | -288.07% |
| EPS Growth | -80.37% | -56.41% | -26.32% | -55.40% | -288.10% |
| EPS Diluted Growth | -80.28% | -57.69% | -25.33% | -55.80% | -288.10% |
| Weighted Average Shares Growth | +0.81% | +0.85% | +1.03% | +0.96% | +0.96% |
| Weighted Average Shares Diluted Growth | +1.28% | +1.02% | +0.60% | +0.34% | +0.11% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -1.76% | -1.32% | -33.73% | +87.23% | -63.85% |
| Free Cash Flow Growth | -18.35% | +0.00% | -39.67% | +129.23% | -62.79% |
| Receivables Growth | -19.71% | -5.72% | -8.54% | -14.17% | -3.89% |
| Inventory Growth | +0.46% | +7.84% | +12.98% | +7.59% | -100.00% |
| Asset Growth | +8.65% | +10.64% | +11.07% | +6.27% | -1.79% |
| Book Value per Share Growth | +0.00% | +1019.68% | +403.84% | +82.02% | +57.80% |
| Debt Growth | +1.18% | +2.78% | +2.77% | +0.90% | -2.61% |
| R&D Expense Growth | -2.99% | -14.29% | -18.10% | -24.32% | -30.00% |
| SG&A Expenses Growth | +0.21% | -2.55% | +3.66% | -1.66% | -7.87% |